Skip to content

LivaNova

$LIVNHealthcare Save LIVN

XNAS · Medical Devices

Last stored close · Nov 10, 2026

Close · Nov 10, 2026

$91.14-1.59%

The live price is free with an account

Model Target

available with Pro

Implied upside

vs the model target

Valuation methods

the methods behind the target

76/100

Strong

QUALITY72VALUE74TECH96RISK69SENT51
Quality & growth72
Valuation74
Technical96
Risk69
Sentiment Signal51

weighted blend of the five model families · nightly cross-sectional scoring · the Sentiment Signal breathes intraday

LivaNova scores 76 out of 100 overall, which we rate strong. Technical is its strongest area and Sentiment Signal its weakest.

Computed summary · a narrated read appears after the next narration pass

What helps

  • Technical
  • Quality & growth
  • Valuation

What to watch

    AI narration of the model output · research, not investment advice · Nov 10, 2026, 21:47 UTC

    Price history

    LIVN · 260 stored daily closes · Oct 29, 2025 – Nov 10, 2026+70.9% over the series
    $50.00$60.00$70.00$80.00$90.00Oct 29, 2025Mar 5, 2026Jul 10, 2026Nov 10, 2026

    Intraday to five-year windows are free with an account

    Members switch between 1D, 1M, 6M, 1Y, 2Y and 5Y and see the live price. Signed out, this is the one-year stored series the technicals below are computed from.

    Market intelligence

    Peer position

    Healthcare

    #7 / 139sector rank by TickerWhale Score

    TickerWhale Score 76 vs sector average 54.6 (+21.4)

    Revenue growth (industry)Top 50%

    Gross margin (industry)Top 39%

    Return on equity (industry)Top 22%

    P/E (industry)Cheaper than 73%

    Compare with peers →

    Technical analysis

    our read · what classic indicators say

    96/100Strong vs universe

    Ranks 96th of 100 covered names on our technical composite — the composite itself scores 84/100 · 25% of the TickerWhale Score

    Strong Buy

    5 buy · 1 sell · 2 neutral of 8 votes

    Textbook signals on this stock alone — not part of the TickerWhale Score

    TickerWhale rates LIVN's technical setup strong — 96th percentile of the covered universe. Classic chart indicators lean buy, pointing the same way.

    9 / 9constructive

    • vs 200-day+23.5%
    • vs 50-day+14.3%

    Mixed

    • RSI (14)66 · neutral
    • Stochasticsell
    • CCIbuy
    • Williams %Rneutral

    Constructive

    • ADX (14) trend strength28· trending
    • MACD (12,26,9)buy(histogram 1.283)

    8 votes · 9 moving averages count as one · Bollinger %B never votes

    Strong Sell
    Sell
    Neutral
    Buy
    ▲ Strong Buy

    Moving averages (9) agree on buy — 9 buy vs 0 sell — and carry one vote between them.

    Oscillators (7) vote individually: 4 buy · 1 sell · 2 neutral.

    Result — 5 buy vs 1 sell of 8 votes = Strong Buy. Neutral votes never decide the verdict.

    Across all 17 tracked indicators: 13 buy · 3 neutral · 1 sell — a different count from the 8 votes above, because the 9 averages are counted individually here · true range basis · data as of Nov 10, 2026

    Fundamentals & valuation

    2026-11-10 · revised_latest
    • P/E (TTM)27.2
    • P/S (TTM)3.5
    • P/B3.9
    • EV/EBITDA—
    • EV/Sales3.3
    • PEG—
    • Gross margin68.1%
    • Net margin12.8%
    • ROE14.9%
    • Debt/Equity0.22
    • Revenue growth (YoY)12.4%
    • EPS growth (YoY)—

    Green favourable · red stretched — multiples and D/E vs industry peers, margins and growth vs absolute thresholds.

    Market capitalisation — $5.1B

    Fundamentals history

    Reported statement totals across recent periods.

    No annual statement history is available for this security yet.

    Fundamentals are stored revised/latest (ADR-009): each period reflects the most recent vendor refresh, NOT point-in-time as-reported values. Do not use this series to claim what was known on a past date.

    Model Target

    Model Target is a Pro feature

    Scores, factors and technicals stay free. The model's price target is part of TickerWhale Pro.

    The Model Target is a TickerWhale Pro feature

    A target exists for this name — the model priced it in the latest nightly run. Pro members see the target, its range and the methods behind it; one name's target is free every trading day.

    Or see the current free one: KNSA →

    Peers

    CompanyScorePulseP/EP/E fwdP/BEV/SalesPriceChgEstimateUpsideRev. gr.
    LIVNCurrentLivaNova768427.2—3.93.3$91.14-1.59%+12.4%
    EXELExelixis828821.3—9.97.4$70.58-1.62%+9.2%
    KNSAKiniksa Pharmaceuticals International plc. -798198.2—12.19.3$95.02-3.79%+58.9%
    THCTenet Healthcare798110.9—5.21.6$290.27+0.44%+7.5%
    INCYIncyte766715.5—3.93.6$120.30-1.30%+26.9%
    OSCROscar Health Inc -767120.3—5.40.5$33.47+4.14%+43.1%

    News, sentiment, the Street view and Ask Willy are free with an account

    A free account shows the stories attached to this name, the Sentiment Signal breakdown, analyst consensus, the options read and the AI narration of the model output.